Biodesix Inc. (BDSX)
NASDAQ · Healthcare
Biodesix Inc. Shareholder Equity 2019–2025
Biodesix Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Biodesix Inc. shareholder equity for the quarter ending December 31, 2025 were -2.5M, a 111.81% decrease year-over-year.
- Biodesix Inc. shareholder equity for 2025 were -2.5M, a 111.81% decrease from 2024.
- Biodesix Inc. shareholder equity for 2024 were 20.9M, a 355.81% increase from 2023.
- Biodesix Inc. shareholder equity for 2023 were 4.6M, a 77.77% decrease from 2022.
- Biodesix Inc. shareholder equity for 2022 were 20.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Biodesix Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-2 |
| 2024 | $21 |
| 2023 | $5 |
| 2022 | $21 |
| 2021 | $20 |
| 2020 | $41 |
| 2019 | $-225 |
| Biodesix Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-2 |
| 2024-12-31 | $21 |
| 2023-12-31 | $5 |
| 2022-12-31 | $21 |
| 2021-12-31 | $20 |
| 2020-12-31 | $41 |
| 2019-12-31 | $-225 |
Biodesix Inc. Shareholder Equity — FAQ
Biodesix Inc. (BDSX) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDSX's shareholder equity history?
The chart and table above show Biodesix Inc.'s shareholder equity by year and by quarter, including the growth rate.